Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Pharmacol., 02 December 2025

Sec. Experimental Pharmacology and Drug Discovery

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1701885

The protective effects and mechanisms of rosmarinic acid against Pseudomonas aeruginosa infection in Caenorhabditis elegans

Ying Zhang&#x;Ying Zhang1Chengjie Shu&#x;Chengjie Shu2Zhuohang LiZhuohang Li2Man QuMan Qu3Chunwu WangChunwu Wang4Shihui NieShihui Nie5Qijiang XuQijiang Xu5Shunlin GuShunlin Gu6Mingjie FanMingjie Fan7Baojun Shi,Baojun Shi1,2Lei Fu
Lei Fu2*Fenglun Zhang
Fenglun Zhang2*
  • 1School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
  • 2Nanjing Institute for Comprehensive Utilization of Wild Plants, Nanjing, China
  • 3School of Basic Medical Sciences and School of Public Health, Faculty of Medicine, Yangzhou University, Yangzhou, China
  • 4Xinjiang Agricultural Technology Promotion Station, Urumqi, China
  • 5Xinjiang Academy of Agricultural Sciences, Urumqi, China
  • 6Yuepuhu Cumin Science and Technology Institute Co., Ltd., Kashgar, China
  • 7Xinjiang Yuanda Green Agriculture Development Co., Ltd., Kashgar, China

Introduction: Pseudomonas aeruginosa poses a significant risk to both the environment and organisms. Although the natural compound rosmarinic acid (RA) has demonstrated considerable antibacterial properties, its efficacy in combating P. aeruginosa infection remains vague.

Methods: Using Caenorhabditis elegans as an infection model, we evaluated the damage induced by PA14, examining indicators including lifespan, locomotor behavior, pharyngeal pumping, excretion cycle, lipofuscin, reactive oxygen species (ROS), as well as mitochondrial membrane potential (MMP) and the expression of mitochondrial-related genes mev-1 and gas-1.

Results: PA14 infection had a diverse effect on C. elegans, including reduced lifespan, impaired behavioral functions (diminished head thrashing frequency, body bending frequency, and pharyngeal pumping frequency, as well as a prolonged excretion cycle), increased lipofuscin and ROS accumulation, and mitochondrial dysfunction (lower MMP and ATP content). RA treatment at concentrations of 100-300 mg/L dose-dependently reduced the number of PA14 colonies in the nematodes, prolonged the lifespan of the infected nematodes, improved behavioral impairments, decreased lipofuscin and ROS accumulation, and alleviated oxidative stress. Mechanistically, RA upregulated the expression profiles of the mev-1 and gas-1 mitochondrial-related genes involved in mitochondrial complex assembly and function. This enhanced MMP and ATP synthesis and mitigated PA14-induced mitochondrial dysfunction.

Discussion: These results indicated that RA protected C. elegans from PA14 infection via its antioxidant properties and its ability to improve mitochondrial function, highlighting its potential as a natural compound for addressing PA14 contamination.

1 Introduction

Pseudomonas aeruginosa functions as a Gram-negative pathogenic bacterium widely distributed in the natural environment, including soil, water, air, and various moist surfaces (Velonakis et al., 2014). It secretes a variety of extracellular enzymes and toxins, which disrupt the balance of the surrounding microbial community, inhibit the growth of beneficial microorganisms, and affect the material cycle and energy flow in the ecosystem (Gellatly and Hancock, 2013). In soil, P. aeruginosa reduces the soil microbial diversity, impairs plant growth and development, and disrupts ecological balance (Licea-Herrera et al., 2024; Thomas and Sekhar, 2016). Massive P. aeruginosa proliferation in water bodies may cause water eutrophication, while secreted metabolites, such as pyocyanin, are toxic to aquatic organisms, threatening their survival and the marine ecosystem (Mena and Gerba, 2009). P. aeruginosa can cause chronic, acute, and refractory infections in mammals and invertebrates, and it is a key pathogen inducing pneumonia. In cystic fibrosis mice, P. aeruginosa exacerbates the deterioration of lung function and is one of the main factors contributing to their death (Matsumoto et al., 2016; Van’t Wout et al., 2015).

Caenorhabditis elegans is commonly utilized to investigate the mechanisms underlying pathogenic infection. This transparent nematode has a short developmental cycle, allowing the direct observation of pathogenic colonization, dissemination, and pathological changes in host tissues in vivo (Kumar et al., 2020). Additionally, the phenotypic changes after infection, such as death, developmental arrest, and intestinal lesions, can be monitored in a short timeframe. Advanced genetic techniques, such as gene knockout, transgenesis, and RNA interference (RNAi), are typically used to analyze host gene function during infection. As a simplified host model, C. elegans enables the intuitive elucidation of host–pathogen interaction mechanisms (Balla and Troemel, 2013). C. elegans exhibits stress responses after infection, allowing clarification of the infection mechanisms via factors such as heat shock protein expression and oxidative stress pathway activation (Servello and Apfeld, 2020). For example, infecting C. elegans with Klebsiella pneumoniae upregulates the hsp-16 gene (a heat shock protein gene), enhancing the survival rate by repairing protein damage, which is consistent with the heat shock response mechanism in human infections (Kamaladevi and Balamurugan, 2017; Schmauder et al., 2022). The innate immune pathways of C. elegans represent a “simplified version” of the immune mechanisms of more complex organisms (Ermolaeva and Schumacher, 2014). For instance, the p38 MAPK pathway is highly conserved with the p38-mediated inflammatory factor release mechanism in human macrophages. Its activation induces the expression of antimicrobial peptides, which is crucial for C. elegans resistance to Gram-negative bacterial infections (Kim et al., 2002; Yang et al., 2022). Signaling pathways such as the insulin-like pathway regulate C. elegans aging and participate in infection responses, linking aging with infection susceptibility, regulating aging-related genes, enhancing antimicrobial peptide expression, and prolonging survival time after infection (Venz et al., 2021; Lee and Lee, 2022).

Rosmarinic acid (RA) is a natural phenolic acid compound widely distributed in plant families such as Apiaceae, Lamiaceae, Boraginaceae, and Cucurbitaceae and in Cuminum cyminum L. (Petersen and Simmonds, 2003). Cumin is a significant natural source of the potent antioxidant RA, which may be more concentrated in immature cumin seeds due to higher metabolic activity in response to environmental challenges such as ultraviolet radiation and microbial invasion (Bettaieb, I et al., 2010; Bettaieb Rebey et al., 2011). In addition to cumin, RA is also found in plants such as rosemary, mint, and perilla. Recent years have seen significant advancement in research on the pharmacological effects of RA. Studies have shown that RA displays various biological activities, including antibacterial, anti-inflammatory, antioxidant, antitumor, and neuroprotective properties (Guan et al., 2022). It can inhibit various bacteria, fungi, and viruses, while its action mechanisms may be related to the disruption of microbial cell membrane structures and the inhibition of nucleic acid and protein synthesis. Furthermore, the antioxidant ability of RA allows it to scavenge free radicals in the body and reduce oxidative stress-induced cell damage, showing potential for preventing and treating various diseases (Gui et al., 2021). Current research on the pharmacological effects of RA focuses on molecular mechanisms, providing a solid theoretical basis for its clinical application.

PA14 is a strain of P. aeruginosa and is used to establish multi-host pathogenic models. Owing to its high pathogenicity, complete genome, and ease of cultivation, PA14 has become a classic model strain for studying virulence factors, quorum sensing (QS) systems, antimicrobial screening, and host–pathogen interactions of P. aeruginosa (Grace et al., 2025). PA14 is highly compatible with the C. elegans model and is one of the most widely used strains in C. elegans pathogenic models. It has been extensively applied in researching bacterial virulence, host immunity, behavioral learning, and drug screening (Tan et al., 1999). Feinbaum et al. (2012) performed genome-wide screening of virulence genes using the C. elegans infection model and validated the compatibility and reliability of PA14 in this model. In summary, this study utilizes PA14 as the pathogen in the infection model and C. elegans as the host organism. PA14 exhibits strong pathogenicity, while its biological characteristics are highly compatible with the advantages of the C. elegans model, enabling efficient simulation of the key processes involved in the “host–pathogen interaction” (Grace et al., 2022; Wang et al., 2021). Although RA is a natural compound with multiple pharmacological activities, its ability to inhibit PA14 infection and its underlying mechanism remain unclear. This study explores the protective effect and mechanism of RA against P. aeruginosa infection in C. elegans, providing a theoretical basis and experimental foundation for the development of natural compounds against P. aeruginosa infection.

2 Materials and methods

2.1 Husbandry of animals

Wild-type N2 C. elegans were cultured on nematode growth medium (NGM) plates and fed with E. coli OP50 to maintain worm development. Gravid nematodes were treated with a lysis solution (a 1:1 volume mixture of 10% NaClO and 1 M NaOH) for nematode synchronization. The collected eggs were placed on new NGM plates and cultured to the young adult stage for experimental use (Hunt, 2017).

2.2 C. elegans infection with PA14

PA14 was cultured in Luria–Bertani (LB) broth and then inoculated onto modified NGM killing plates containing 0.35% peptone. The cultures were incubated at 37 °C for 24 h, followed by further incubation at 25 °C for another 24 h. The synchronized young adults were transferred to NGM plates containing PA14, at 50 worms per plate, and incubated at a constant temperature of 20 °C (Yuan et al., 2024).

2.3 Rosmarinic acid exposure

Post-PA14 infection, the synchronized L4-stage worms were kept under continuous exposure to various RA concentrations (100 mg/L, 200 mg/L, and 300 mg/L) over a 24-h period.

2.4 Colony count determination

After synchronization, the worms were cultured in groups with PA14 and different RA concentrations. After repeated washing with M9 buffer to remove the bacteria adhering to the body surfaces, 50 worms from each group were transferred to a grinder to disrupt the nematode body wall and release internal bacteria. The bacterial suspension was serially diluted, spread on LB culture plates, and incubated at 37 °C, after which the number of colonies was determined (Zhang, L. et al., 2022). Three repetitions of the experiment were performed.

2.5 Lifespan assay

Young adult nematodes exposed to the drug or infected with PA14 were placed on NGM agar plates seeded with OP50 using a platinum wire needle. For each group, 30 worms were selected in duplicate, and the cultures were maintained at a constant temperature of 20 °C. The lifespan measurements began on the day the worms were placed on the plates. Worms were deemed dead in instances where they did not move for 5 s after coming into contact with the platinum wire needle (Park et al., 2017). The survival rates of the nematodes were recorded daily until all the worms in a group were deceased. The point at which half of the nematodes in a group had died was designated as the median lifespan.

2.6 Behavioral analysis

A microscope was used to observe the head-waving and body-bending frequencies. A successful head wave was characterized by a change in the head movement direction that aligned with the orientation of the body, while a body bend was defined as the sinusoidal movement of the nematode body along its S-shaped midline (Zhang, H. et al., 2022). The body-bending and head-thrashing frequencies were recorded for 1 min, with the results expressed as bends and thrashes per minute. Twenty worms from each group were observed, and three repetitions of the experiment were performed.

The pharyngeal pumping frequency was observed under a microscope. Successful pharyngeal pumping was defined as a single contraction during the process of swallowing food (Keith et al., 2014). The pumping rate was recorded for 20 s. The excretion cycle was defined as the time required for the nematode body wall muscles to contract and excrete until the next contraction (Wu et al., 2013). Twenty worms from each group were observed, and three repetitions of the experiment were performed.

2.7 Lipofuscin level determination

Synchronized N2 worms were cultured with the respective treatments for 24 h according to their experimental groups and then washed with M9 buffer. Then, 500 μL of 4% paraformaldehyde was added to fix the worms for 20 min. An appropriate number of worms were transferred to 2% agarose pads and imaged under the DAPI channel at a wavelength of 525 nm. Images were analyzed using ImageJ software after normalization with autofluorescence, and the mean pixel density was calculated to assess the level of lipofuscin accumulation in the worms (Shen et al., 2021). Twenty worms from each group were assessed, and three repetitions of the experiment were performed.

2.8 Reactive oxygen species level measurement

The fluorescent probe 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) method was used to detect the reactive oxygen species (ROS) levels in the C. elegans (Lin et al., 2019; Moliner et al., 2020). Worms from the different treatment groups were placed in 96-well plates, after which a 50 μL M9 buffer and 50 μL DCFH-DA mixture was added to each well, followed by incubation for 2 h at 37 °C in the dark while shaking at 100 rpm. After staining, the probe was removed by washing with M9 buffer. Worms from each group were transferred to 2% agarose pads and imaged under the FITC green fluorescent channel, with an excitation wavelength of 485 nm and an emission wavelength of 520 nm. Images were analyzed using ImageJ software after normalization with autofluorescence. Twenty worms from each group were assessed, and three repetitions of the experiment were performed.

2.9 Mitochondrial function determination

The JC-1 probe method functioned to ascertain the mitochondrial membrane potential in the worms (Zhang et al., 2022a). JC-1 assumes a monomeric state under conditions of low membrane potential, which corresponds to green fluorescence with an emission wavelength of 525 nm (λem = 525 nm). In contrast, at high membrane potential, it assembles into aggregates, associated with red fluorescence emitting at 590 nm (λem = 590 nm), with the membrane potential reflected by the red-to-green fluorescence ratio. The JC-1 stock solution was diluted to 5–10 μM with M9 buffer and preheated at 37 °C. Worms from the different groups were resuspended in the JC-1 working solution, incubated in the dark at 20 °C for 20–30 min, placed on 2% agarose pads with 10 mM NaN3 (anesthetic), and imaged using a fluorescence microscope. Processing of the images was carried out using ImageJ to calculate the red-to-green fluorescence intensity ratio (red/green).

Worms from the different treatment groups were rinsed using M9 buffer and transferred to a grinder. They were ground manually in an ice water bath, after which the homogenate was centrifuged at 4500 r/min for 10 min. The supernatant was harvested, and the ATP content was determined according to the instructions of the corresponding kits (Chen et al., 2024). Three repetitions of the experiment were performed.

2.10 Reverse transcription polymerase chain reaction (RT-PCR)

A RNeasy Mini kit (Qiagen, Shanghai, China) was used to extract the total RNA from the nematodes (∼1 mg), which was reverse-transcribed using a cDNA synthesis kit (Bio-Rad Laboratories, Shanghai, China), while SYBR Premix Ex Taq (Takara, Shanghai, China) was used for qRT-PCR. The tba-1 reference protein encoding tubulin was used for relative gene quantification (Wu et al., 2024). The experiment was conducted in triplicate across three groups.

2.11 RNA interference

The dsRNA of the target gene was cloned into the L4440 expression vector, after which the vector plasmid was transformed into E. coli HT115. NGM plates were fortified with 1 mM IPTG and 50 μg/mL ampicillin. The induced bacteria were inoculated onto these NGM plates and cultured at room temperature for 24 h to allow sufficient dsRNA expression (Timmons, 2006). Prior to the experiment, the PA14-infected worms were cultured on RNAi plates and treated with RA.

2.12 Data analysis

The findings are presented as mean ± standard error of the mean (SEM). Statistical differences between data were tested for significance using one-way or two-way analysis of variance (ANOVA). A value of **P < 0.01 represents significant differences. All data were statistically analyzed and plotted using GraphPad Prism 10.1.2.

3 Results

3.1 RA inhibits the number of PA14 colonies in C. elegans

Colony counting indicated that RA significantly reduced the number of colonies in the PA14-infected worms (Figure 1). After treatment with RA at concentrations of 100, 200, and 300 mg/L, the colony count was reduced by 42%, 61%, and 75%, respectively, compared with the PA14 group. These results indicate that as the concentration of RA increases, its inhibitory effect on PA14 is gradually enhanced.

Figure 1
Bar chart showing colony-forming units (CFU) per worm for different treatments. Four bars represent PA14, PA14 with RA at 100, 200, and 300 mg/L. The PA14 bar is the highest, with subsequent PA14 + RA bars showing decreasing CFU values. Statistical significance is indicated by asterisks.

Figure 1. Effect of RA on the number of colonies in C. elegans. **P < 0.01 vs. control.

3.2 RA extends the lifespan of PA14-infected C. elegans

Relative to the control group, PA14 infection significantly reduced the lifespan of the worms (Figure 2). Exposure to different RA concentrations extended the lifespan of the PA14-infected worms to varying degrees (Figure 2), with the effect becoming more pronounced as the RA concentration increased.

Figure 2
Survival analysis and mean lifespan bar graph comparing control and treated groups. The left chart shows survival percentages over time, with various treatments having different effects. The right bar graph displays mean lifespan in days, with the control group outliving all treatments, while significance is indicated with asterisks between groups.

Figure 2. Ability of RA to improve the lifespan of PA14-infected C. elegans. **P < 0.01.

3.3 RA ameliorates the healthy behavior of PA14-infected C. elegans

PA14 infection adversely affected the physiological behavior of the worms. Compared to the blank control group, the PA14-infected worms exhibited a significant decrease in head-thrashing, body-bending, and pharyngeal pumping rates (Figures 3A,B), along with a relatively prolonged excretion time (Figure 3C). These results indicated that PA14 impaired the locomotor ability, reduced vitality, and weakened the swallowing and excretion capacity of the worms. Exposure to different RA concentrations alleviated the adverse effect of PA14 on the worms in all three RA-treated groups. Compared to those in the PA14-infected group, the frequencies of head thrashing and body bending, along with the pharyngeal pumping rate, increased significantly (Figures 3A,B), while the excretion cycle was considerably shorter (Figure 3C).

Figure 3
Bar graphs show experimental data on four different parameters: head thrashes per minute, body bends per minute, pump rates per twenty seconds, and defecation in seconds. The graphs compare a control group, PA14, and PA14 with varying concentrations of RA (100 mg/L, 200 mg/L, 300 mg/L). Each parameter displays statistically significant differences, indicated by asterisks. Data points are overlaid as dots on the bars.

Figure 3. Effect of RA on the healthy behavior of PA14-infected C. elegans. (A) Impact of RA on the locomotor behavior of the worms after PA14 infection. **P < 0.01. (B) Impact of RA on the pharyngeal pumping rates of the worms after PA14 infection. **P < 0.01. (C) Effect of RA on the defecation of the worms after PA14 infection. **P < 0.01.

3.4 RA reduces lipofuscin and ROS accumulation in PA14-infected C. elegans

Relative to the blank control group, PA14 infection significantly increased the fluorescence intensity of lipofuscin and ROS in the worms, which decreased after RA treatment (Figures 4A,B). These results indicated that PA14 infection induced oxidative damage in the worms since excessive ROS promoted lipofuscin accumulation. Treatment with RA significantly reduced the levels of lipofuscin and ROS.

Figure 4
Panel A shows fluorescence images and a bar chart of lipofuscin relative fluorescence intensity. The control and PA14 samples are compared to PA14 with RA treatments at 100, 200, and 300 mg/L. The bar chart indicates significant differences marked by asterisks. Panel B features fluorescence images and a bar chart for ROS relative fluorescence intensity, also comparing control and PA14 samples with PA14 plus RA treatments. Significant differences are similarly marked.

Figure 4. RA modulates lipofuscin and ROS accumulation in PA14-infected C. elegans. (A) Effect of RA on the lipofuscin level in the PA14-infected worms. **P < 0.01. (B) Effect of RA on the ROS level in the PA14-infected worms. **P < 0.01.

3.5 RA enhances mitochondrial function in PA14-infected C. elegans

PA14 caused oxidative damage in the worms. Excessive ROS accumulation impaired the mitochondrial membrane structure and inhibited mitochondrial function (Lei et al., 2013). The MMP measurements were used to further investigate the impact of PA14 on the mitochondria of the worms. The worms infected by PA14 displayed a decrease in the proportion of mitochondria exhibiting high membrane potential (red fluorescence) and an increase in those showing low membrane potential (green fluorescence), reducing the total membrane potential. RA treatment decreased the proportion of mitochondria displaying low membrane potential (green fluorescence) and increased the total membrane potential (Figure 5A).

Figure 5
Panel A shows fluorescence images of samples under different conditions: control, PA14, and PA14 with RA at 100, 200, and 300 mg/L. The top row displays green fluorescence, and the bottom row shows red. Panel B is a bar graph indicating the relative red/green ratio, with control having the highest ratio, decreasing significantly in PA14 and increasing slightly with added RA. Panel C is a bar graph depicting ATP levels in nmol/mg protein, highest in the control, lower in PA14, and increasing with RA concentration. Statistical significance is denoted by asterisks.

Figure 5. RA modulates mitochondrial function in PA14-infected C. elegans. (A,B) The effect of RA on the MMP of the PA14-infected worms. **P < 0.01. (C) The effect of RA on the ATP of the PA14-infected worms. **P < 0.01.

The experiments demonstrated that a significant decrease in the ATP content accompanied the PA14-induced reduction in the MMP of the worms. Contrarily, RA treatment increased both the ATP level and MMP (Figure 5B), with the overall trend consistent with the MMP results. Additionally, the efficacy of RA was enhanced as its concentration increased, exhibiting a clear dose-dependent effect.

3.6 The effect of RA on mev-1 and gas-1 in PA14-infected C. elegans

Previous studies have found that phb-1 and phb-2 can affect the MMP of C. elegans (Qu et al., 2023). Verified in this experiment, PA14 infection of C. elegans triggers stress and immune responses, accompanied by upregulated expression levels of phb-1 and phb-2 (Figure 6A). After treatment with RA, the expression levels of these two genes decrease and approach the normal level. This indicates that RA combats PA14 infection by regulating mitochondria. The mitochondrial mev-1 and gas-1 genes in C. elegans are involved in the assembly and function of mitochondrial complexes I and II, respectively (Li et al., 2018; Kayser et al., 2001). The expression levels of mev-1 and gas-1 decreased significantly in the PA14-infected worms but were alleviated by RA treatment (Figure 6B). RA treatment reduced the locomotor ability of the worms displaying mev-1 and gas-1 RNAi (Figure 6C) while increasing ROS accumulation in vivo (Figure 6D).

Figure 6
Graphs and micrographs illustrate the effects of treatments on gene expression and behavior. Panel A shows bar graphs of pflh-1 and pflh-2 mRNA levels, with PA14 and PA14+RA treatments leading to increased expression. Panel B depicts bar graphs of mev-1 and gas-1 mRNA levels, with reductions under PA14, and increases with PA14+RA. Panel C shows bar graphs of head thrashes and body bends per minute, affected differently by various treatments. Panel D displays micrographs of samples under different conditions and a bar graph showing the relative fluorescence intensity, indicating variations in response to treatments.

Figure 6. RA regulates the phb-1, phb-2, mev-1, and gas-1 genes in PA14-infected C. elegans. (A) phb-1 and phb-2 expression after RA treatment (B) mev-1 and gas-1 expression after RA treatment. Effect of RA on the (C) locomotor behavior and (D) ROS of the PA14-infected worms with RNAi mev-1 and gas-1. The RA exposure concentration was 300 mg/L. **P < 0.01.

3.7 Evaluation of the safety of RA on C. elegans

When C. elegans was treated with RA, the lifespan curves of the nematodes shifted to the right at all three concentrations. In terms of the mean lifespan, a 300 mg/L concentration facilitated the most pronounced extension of the nematode lifespan (Figure 7A). Regarding locomotion, RA significantly enhanced the frequencies of nematode head thrashing and body bending compared to the blank group, showing a dose-dependent effect (Figure 7B). RA also positively affected pharyngeal pumping and excretion of the worms. RA treatment increased the pharyngeal pumping rate and reduced the excretion cycle, exhibiting a similar dose-dependent effect (Figures 7C,D).

Figure 7
Four-part graph showing experimental results:A) Line graph of survival percentage over 30 days with different treatments: control (black), 100 mg/L (blue), 200 mg/L (green), 300 mg/L (orange). Decreasing trends are noted, with higher concentrations showing decreased survival earlier.B) Bar graphs for head thrashes per minute (left) and body bends per minute (right) under control and varied concentrations. Higher concentrations show increased activity.C) Bar graph of pump rates per 20 seconds. Increased rates with higher concentrations.D) Bar graph of defecation duration (seconds) showing variations across different treatments, with higher concentrations exhibiting increased times.Statistical significance is indicated throughout.

Figure 7. Effects of RA on the (A) lifespan, (B) locomotor behavior, (C) pharyngeal pumping rate, and (D) excretion cycle of C. elegans. **P < 0.01 vs. control.

4 Discussion

P. aeruginosa is a widely distributed Gram-negative pathogenic bacterium that causes damage to the ecological environment, such as reducing soil microbial diversity and inducing water eutrophication. It can also infect animals, plants, and humans, leading to diseases such as pneumonia, exacerbating the deterioration of lung function in cystic fibrosis, and even causing death (Wood et al., 2023). RA, a naturally occurring phenolic acid compound, exhibits a range of biological activities, encompassing antibacterial, antioxidant, and anti-inflammatory properties (Guan et al., 2022). However, the specific mechanisms underlying its ability to resist PA14 infections remain unclear.

Numerous studies have demonstrated the effects of RA in the C. elegans model, and its mechanism of action is closely associated with evolutionarily conserved signaling pathways. RA extends the lifespan of C. elegans while maintaining their reproductive capacity and effectively delays age-related phenotypic deterioration; this process is associated with changes in the expression of core regulatory genes in the insulin/insulin-like growth factor signaling pathway and the p38 MAPK pathway (Wang et al., 2012). Antioxidant stress resistance is a core active feature of RA. It enhances the activity of antioxidant enzymes in C. elegans, regulates the glutathione redox balance, and strengthens the nematodes' resistance to heat stress and oxidative toxicants (Lin et al., 2019). This effect is directly associated with the activation of the expression of downstream antioxidant-related genes. Additionally, in the field of neuroprotection (Chen et al., 2024), RA can inhibit the abnormal aggregation of pathogenic proteins and reduce neuronal damage in C. elegans models of Alzheimer’s disease, Huntington’s disease, and Parkinson’s disease. Its protective effect may be associated with the improvement of oxidative stress status and mitochondrial dysfunction.

This study demonstrated that RA displayed a dose-dependent ameliorative effect on PA14-infected C. elegans in a concentration range of 100–300 mg/L. Colony counting experiments showed that PA14 infection significantly increased the bacterial number in the bodies of the C. elegans worms, while RA treatment substantially reduced the number of colonies (Figure 1). Our findings demonstrated that RA mitigated the adverse implication of PA14 on the worm lifespan, exhibiting a clear dose-dependent relationship. This indicated that RA directly inhibited the colonization ability of PA14 in the host, while a higher RA concentration enhanced the antibacterial effect. This may be because RA disrupts the PA14 cell membrane structure or inhibits its nucleic acid and protein synthesis, consequently reducing intestinal bacterial proliferation (Zhang et al., 2022b).

PA14 infection significantly reduced the nematode lifespan, which was prolonged by RA treatment in a dose-dependent manner. Among the various treatment groups, the median lifespan was most notably extended in the 300 mg/L RA group compared with the infected group (Figure 2). Our findings demonstrated that RA mitigated the adverse implication of PA14 on the worm lifespan, exhibiting a clear dose-dependent relationship. Behavioral analysis further confirmed that RA ameliorated PA14-induced behavioral deficits (Figure 3A). As shown in Figure 3B, a higher RA concentration significantly improved the pharyngeal pumping frequency of the nematodes, which reflected feeding ability (Trojanowski et al., 2016). Furthermore, RA treatment reduced the excretion cycle, an indicator of intestinal function and metabolic capacity (Spanier et al., 2009), suggesting that RA repaired the intestinal function of nematodes and enhanced their metabolic capacity (Figure 3C). The results obtained indicated that the ability of RA to improve the life quality of infected nematodes was clearly dose-dependent, with higher RA concentrations proving to be more effective in restoring their motor, feeding, and intestinal functions.

PA14 infection resulted in significant ROS and lipofuscin (a marker of oxidative damage) accumulation in the nematodes. Experimental results revealed that RA mitigated lipofuscin and ROS aggregation in the PA14-infected worms (Figure 4), alleviated the related oxidative damage, and exhibited a dose–effect relationship. This phenomenon was directly related to the strong antioxidant activity of RA (Villalva et al., 2018), which alleviated the oxidative stress damage induced by PA14 infection through pathways such as scavenging of free radicals and inhibition of lipid peroxidation.

Mitochondria are vital to cellular energy metabolism and are the primary target of oxidative stress-induced damage (Kakkar and Singh, 2007). This study found that the anti-infective effect of RA was closely associated with improved mitochondrial function. Experimental studies have revealed that infection with PA14 impairs mitochondrial function in C. elegans. According to experimental results, excessive ROS levels directly attack the mitochondrial membrane structure, leading to a decrease in MMP (Figure 5A). MMP converts the energy generated by the electron transport chain into ATP through chemiosmotic potential (Boyer, 1997); therefore, a decrease in MMP simultaneously results in impaired ATP synthesis and a reduction in ATP levels (Figure 5B). Moreover, surplus ROS also corroborated mitochondrial function impairment, further exacerbating ROS release, creating a vicious cycle of oxidative stress and mitochondrial damage (Gallo et al., 2024). This damage directly affected the physiological functions of C. elegans. ATP deficiency reduced muscle contractility (Galimov et al., 2018), which manifested as lower head swing and body bend frequency (Figure 3A). Abnormal mitochondrial function in intestinal cells impaired digestion and excretion (Williams et al., 2022), which decreased the pharyngeal pumping frequency and prolonged the excretion cycle (Figures 3B,C). Furthermore, the accelerated cellular senescence (lipofuscin accumulation) caused by mitochondrial damage, combined with insufficient energy supply, collectively reduced the C. elegans lifespan. The experiment revealed that RA improved mitochondrial function via dual mechanisms. First, RA exhibited direct antioxidant effects. It reduced oxidative damage to mitochondrial membranes by decreasing ROS accumulation, consequently increasing the MMP by 58% in the 300 mg/L group (Figure 5A) and elevating ATP synthesis by 65% (Figure 5B). This enhanced mitochondrial energy metabolism, which provided energy for cellular activities. The restoration of mitochondrial function directly reversed the adverse effect of PA14 infection. An increase in the ATP supply restored muscle function, which significantly improved the behavioral indicators, including the frequencies of head swings, body bends, and pharyngeal pumping. Balanced energy metabolism delayed cellular senescence, reduced lipofuscin deposition, and prolonged the C. elegans lifespan. The results indicated that mitochondrial function served as the central hub through which RA exerted its multifaceted anti-infective effects. Behavioral improvements, oxidative stress alleviation, and lifespan extension all relied on MMP stability and increased ATP synthesis. This finding highlighted the central role of mitochondria in the host resistance to PA14 infection and provided a clear functional target for the anti-infective mechanism of RA.

The results further confirmed that RA protected mitochondrial function by upregulating the expression levels of mev-1 and gas-1, mitochondrial function-related genes. The mev-1 gene encodes a key subunit of mitochondrial complex I and is involved in the assembly and functional maintenance of the electron transport chain. The gas-1 gene regulates the activity of mitochondrial complex II, while both collectively affect the efficiency of mitochondrial oxidative phosphorylation (Li et al., 2018; Kayser et al., 2001). PA14 infection significantly downregulated mev-1 and gas-1 expression (Figure 6A), impairing complex I and II functionality, which in turn decreased the synthesis of MMP and ATP. This gene expression downregulation represents a vital molecular mechanism through which PA14 disrupts mitochondrial function.

RA treatment reversed the PA14-induced inhibition of mev-1 and gas-1, consequently upregulating their expression (Figure 6A). The restoration of gene expression directly promoted the assembly and functional activation of mitochondrial complexes, as evidenced by increased MMP and ATP synthesis. These results indicated that RA fundamentally improved mitochondrial function by regulating core mitochondrial genes at the transcriptional level. RNAi experiments further validated the critical role of mev-1 and gas-1. Silencing these two genes significantly attenuated the protective effect of RA on infected nematodes, as reflected by lower ROS accumulation and improved locomotor activity (Figures 6B,C). By upregulating the expression levels of the mev-1 and gas-1 mitochondria-related genes, RA promoted the assembly and functional activation of mitochondrial complexes I and II, enhanced MMP and ATP synthesis, and reduced ROS accumulation, consequently disrupting the “gene downregulation–mitochondrial dysfunction–oxidative stress” vicious cycle triggered by PA14 infection. Ultimately, this inhibited bacterial proliferation, improved behavioral function, alleviated oxidative damage, and extended lifespan. These findings confirmed that mev-1 and gas-1 represented key targets for RA action, while their upregulated expression formed the molecular basis for the enhancement of mitochondrial function and anti-infection properties by RA.

In this research, C. elegans was adopted as a model organism to systematically investigate the role of RA in combating PA14 infection and the underlying molecular mechanisms. Within a specific dose range, RA prolonged the lifespan of C. elegans and enhanced their locomotor capacity, feeding ability, and intestinal function. The results showed that RA inhibited PA14 infection in a dose-dependent manner, which was closely associated with enhanced antioxidant activity, improved mitochondrial function, and regulation of mitochondria-related genes. In addition to the antioxidative and mitochondrial protective mechanisms highlighted in this study, the ability of RA to inhibit PA14 infection may also stem from its role in enhancing host immune response. Future studies can further explore whether RA enhances host resistance to pathogens by regulating immune-related genes.

P. aeruginosa displays strong environmental adaptability, easily surviving and reproducing in humid environments, and demonstrating considerable potential for causing pollution. RA, a naturally occurring compound, is present in diverse plant species, offering advantages such as low toxicity, easy extraction, and multi-target properties. Genes of C. elegans share high sequence conservation with human genes. In experiments, the C. elegans genes phb-1, phb-2, mev-1, and gas-1 correspond to the human homologous genes PHB-1 (Nijtmans et al., 2002), PHB-2 (Nijtmans et al., 2002), SDHC (Ishii et al., 2011), and NDUFS2 (Pujol et al., 2013), respectively. The mechanism by which RA combats PA14 infection by regulating these four genes in the C. elegans model can provide target references for the treatment of human diseases caused by PA infection.

RA naturally exhibits extremely low oral bioavailability (<10%), mainly limited by poor lipophilicity, degradation by intestinal flora, and hepatic first-pass metabolism (Kang et al., 2021). Nearly complete absorption can be achieved via direct intravenous/intraperitoneal administration; transdermal administration requires penetration enhancers to overcome the skin barrier; nasal or pulmonary nebulization enables targeted delivery to the brain or lungs (Hitl et al., 2021); for oral administration, technologies such as self-microemulsifying systems, esterified derivatives, or co-administration with flavonoids/piperine can increase its bioavailability by 1.7–9 folds, meeting diverse clinical needs (Kang et al., 2021). This study provides a theoretical basis for the use of RA in the treatment of P. aeruginosa infections. RA can serve as an adjuvant for the clinical treatment of P. aeruginosa infections; however, further research is still needed to explore ways to improve its bioavailability and develop more dosage forms, thereby enabling it to function as a primary therapeutic drug against P. aeruginosa infections.

5 Conclusion

The C. elegans animal model showed that PA14 infection caused varying degrees of damage in the worms, ranging from organismal phenotypes to mitochondrial dysfunction. Treatment with different RA concentrations ranging between 100 mg/L and 300 mg/L exhibited a dose-dependent effect on the lifespan, locomotion, swallowing, and excretion of the infected worms. Additionally, RA reduced lipofuscin accumulation, counteracted PA14-induced ROS production, and significantly alleviated oxidative stress. Furthermore, RA mitigated PA14-induced mitochondrial dysfunction by regulating the mev-1 and gas-1 mitochondria-related genes, consequently enhancing the MMP and ATP synthesis. The high toxicity and infectivity of PA14 present substantial threats to both the environment and organisms. Therefore, this research demonstrated that RA inhibited the damage caused by PA14 infection, highlighting its potential as a natural compound for addressing PA14 infection.

Data availability statement

The original data presented in the study are included in the article; further inquiries can be directed to the corresponding author.

Ethics statement

The manuscript presents research on animals that do not require ethical approval for their study.

Author contributions

YZ: Data curation, Formal Analysis, Investigation, Software, Visualization, Writing – original draft. CS: Formal Analysis, Investigation, Methodology, Visualization, Writing – original draft. ZL: Data curation, Formal Analysis, Investigation, Methodology, Visualization, Writing – original draft. MQ: Formal Analysis, Investigation, Methodology, Visualization, Writing – review and editing. CW: Formal Analysis, Investigation, Methodology, Visualization, Writing – review and editing. SN: Methodology, Resources, Validation, Writing – review and editing. QX: Formal Analysis, Methodology, Validation, Writing – review and editing. SG: Conceptualization, Supervision, Validation, Writing – review and editing. MF: Conceptualization, Formal Analysis, Investigation, Supervision, Validation, Writing – review and editing. BS: Conceptualization, Investigation, Validation, Writing – review and editing. LF: Formal Analysis, Methodology, Project administration, Resources, Writing – review and editing. FZ: Funding acquisition, Methodology, Resources, Validation, Writing – review and editing.

Funding

The authors declare that financial support was received for the research and/or publication of this article. This work was supported by the Key Research and Development Program in Xinjiang Province of China (2023B02025) and the National Key Research and Development Program of China (2024YFD1600800).

Conflict of interest

Author SG was employed by Yuepuhu Cumin Science and Technology Institute Co., Ltd.

Author MF was employed by Xinjiang Yuanda Green Agriculture Development Co., Ltd.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The authors declare that no Generative AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2025.1701885/full#supplementary-material

References

Balla, K. M., and Troemel, E. R. (2013). Caenorhabditis elegans as a model for intracellular pathogen infection. Cell Microbiol. 15, 1313–1322. doi:10.1111/cmi.12152

PubMed Abstract | CrossRef Full Text | Google Scholar

Bettaieb, I., Bourgou, S., Wannes, W. A., Hamrouni, I., Limam, F., and Marzouk, B. (2010). Essential oils, phenolics, and antioxidant activities of different parts of cumin (Cuminum cyminum L.). J. Agric. Food Chem. 58, 10410–10418. doi:10.1021/jf102248j

PubMed Abstract | CrossRef Full Text | Google Scholar

Bettaieb Rebey, I., Bourgou, S., Ben Slimen Debez, I., Jabri Karoui, I., Hamrouni Sellami, I., Msaada, K., et al. (2011). Effects of extraction solvents and provenances on phenolic contents and antioxidant activities of cumin (Cuminum cyminum L.) seeds. Food Bioprocess Technol. 5, 2827–2836. doi:10.1007/s11947-011-0625-4

CrossRef Full Text | Google Scholar

Boyer, P. D. (1997). The ATP synthase--a splendid molecular machine. Annu. Rev. Biochem. 66, 717–749. doi:10.1146/annurev.biochem.66.1.717

PubMed Abstract | CrossRef Full Text | Google Scholar

Chen, Y., Xu, R., Liu, Q., Zeng, Y., Chen, W., Liu, Y., et al. (2024). Rosmarinic acid ameliorated oxidative stress, neuronal injuries, and mitochondrial dysfunctions mediated by polyglutamine and ɑ-synuclein in Caenorhabditis elegans models. Mol. Neurobiol. 61, 10138–10158. doi:10.1007/s12035-024-04206-4

PubMed Abstract | CrossRef Full Text | Google Scholar

Ermolaeva, M. A., and Schumacher, B. (2014). Insights from the worm: the C. elegans model for innate immunity. Semin. Immunol. 26, 303–309. doi:10.1016/j.smim.2014.04.005

PubMed Abstract | CrossRef Full Text | Google Scholar

Feinbaum, R. L., Urbach, J. M., Liberati, N. T., Djonovic, S., Adonizio, A., Carvunis, A. R., et al. (2012). Genome-wide identification of Pseudomonas aeruginosa virulence-related genes using a Caenorhabditis elegans infection model. PLoS Pathog. 8, e1002813. doi:10.1371/journal.ppat.1002813

PubMed Abstract | CrossRef Full Text | Google Scholar

Galimov, E. R., Pryor, R. E., Poole, S. E., Benedetto, A., Pincus, Z., and Gems, D. (2018). Coupling of rigor mortis and intestinal necrosis during C. elegans organismal death. Cell Rep. 22, 2730–2741. doi:10.1016/j.celrep.2018.02.050

PubMed Abstract | CrossRef Full Text | Google Scholar

Gallo, G., Rubattu, S., and Volpe, M. (2024). Mitochondrial dysfunction in heart failure: from pathophysiological mechanisms to therapeutic opportunities. Int. J. Mol. Sci. 25, 2667. doi:10.3390/ijms25052667

PubMed Abstract | CrossRef Full Text | Google Scholar

Gellatly, S. L., and Hancock, R. E. (2013). Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog. Dis. 67, 159–173. doi:10.1111/2049-632X.12033

PubMed Abstract | CrossRef Full Text | Google Scholar

Grace, A., Sahu, R., Owen, D. R., and Dennis, V. A. (2022). Pseudomonas aeruginosa reference strains PAO1 and PA14: a genomic, phenotypic, and therapeutic review. Front. Microbiol. 13, 1023523. doi:10.3389/fmicb.2022.1023523

PubMed Abstract | CrossRef Full Text | Google Scholar

Grace, A., Sahu, R., Owen, D. R., and Dennis, V. A. (2025). Host-mimicking conditions promote Pseudomonas aeruginosa PA14 virulence gene expression. Front. Microbiol. 16, 1557664. doi:10.3389/fmicb.2025.1557664

PubMed Abstract | CrossRef Full Text | Google Scholar

Guan, H., Luo, W., Bao, B., Cao, Y., Cheng, F., Yu, S., et al. (2022). A comprehensive review of rosmarinic acid: from phytochemistry to pharmacology and its new insight. Molecules 27, 3292. doi:10.3390/molecules27103292

PubMed Abstract | CrossRef Full Text | Google Scholar

Gui, H., Jin, Y., Lin, A., Wang, P., Wang, Y., and Zhu, H. (2021). Rosmarinic acid relieves cisplatin-induced ovary toxicity in female mice via suppression of oxidative stress and inflammation. J. Biochem. Mol. Toxicol. 35, e22839. doi:10.1002/jbt.22839

PubMed Abstract | CrossRef Full Text | Google Scholar

Hitl, M., Kladar, N., Gavarić, N., and Božin, B. (2021). Rosmarinic acid-human pharmacokinetics and health benefits. Planta Med. 87, 273–282. doi:10.1055/a-1301-8648

PubMed Abstract | CrossRef Full Text | Google Scholar

Hunt, P. R. (2017). The C. elegans model in toxicity testing. J. Appl. Toxicol. 37, 50–59. doi:10.1002/jat.3357

PubMed Abstract | CrossRef Full Text | Google Scholar

Ishii, T., Miyazawa, M., Hartman, P. S., and Ishii, N. (2011). Mitochondrial superoxide anion (O(2)(-)) inducible “mev-1” animal models for aging research. BMB Rep. 44, 298–305. doi:10.5483/BMBRep.2011.44.5.298

PubMed Abstract | CrossRef Full Text | Google Scholar

Kakkar, P., and Singh, B. K. (2007). Mitochondria: a hub of redox activities and cellular distress control. Mol. Cell Biochem. 305, 235–253. doi:10.1007/s11010-007-9520-8

PubMed Abstract | CrossRef Full Text | Google Scholar

Kamaladevi, A., and Balamurugan, K. (2017). Global proteomics revealed klebsiella pneumoniae Induced autophagy and oxidative stress in Caenorhabditis elegans by inhibiting PI3K/AKT/mTOR pathway during infection. Front. Cell Infect. Microbiol. 7, 393. doi:10.3389/fcimb.2017.00393

PubMed Abstract | CrossRef Full Text | Google Scholar

Kang, Y. J., Lee, C. H., Park, S. J., Lee, H. S., Choi, M. K., and Song, I. S. (2021). Involvement of organic anion transporters in the pharmacokinetics and drug interaction of rosmarinic acid. Pharmaceutics 13, 83. doi:10.3390/pharmaceutics13010083

PubMed Abstract | CrossRef Full Text | Google Scholar

Kayser, E. B., Morgan, P. G., Hoppel, C. L., and Sedensky, M. M. (2001). Mitochondrial expression and function of GAS-1 in Caenorhabditis elegans. J. Biol. Chem. 276, 20551–20558. doi:10.1074/jbc.M011066200

PubMed Abstract | CrossRef Full Text | Google Scholar

Keith, S. A., Amrit, F. R., Ratnappan, R., and Ghazi, A. (2014). The C. elegans healthspan and stress-resistance assay toolkit. Methods 68, 476–486. doi:10.1016/j.ymeth.2014.04.003

PubMed Abstract | CrossRef Full Text | Google Scholar

Kim, D. H., Feinbaum, R., Alloing, G., Emerson, F. E., Garsin, D. A., Inoue, H., et al. (2002). A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science 297, 623–626. doi:10.1126/science.1073759

PubMed Abstract | CrossRef Full Text | Google Scholar

Kumar, A., Baruah, A., Tomioka, M., Iino, Y., Kalita, M. C., and Khan, M. (2020). Caenorhabditis elegans: a model to understand host-microbe interactions. Cell Mol. Life Sci. 77, 1229–1249. doi:10.1007/s00018-019-03319-7

PubMed Abstract | CrossRef Full Text | Google Scholar

Lee, H., and Lee, S. V. (2022). Recent progress in regulation of aging by Insulin/IGF-1 signaling in Caenorhabditis elegans. Mol. Cells 45, 763–770. doi:10.14348/molcells.2022.0097

PubMed Abstract | CrossRef Full Text | Google Scholar

Lei, L., Tzekov, R., McDowell, J. H., Smith, W. C., Tang, S., and Kaushal, S. (2013). Formation of lipofuscin-like material in the RPE cell by different components of rod outer segments. Exp. Eye Res. 112, 57–67. doi:10.1016/j.exer.2013.04.006

PubMed Abstract | CrossRef Full Text | Google Scholar

Li, W., Wang, D., and Wang, D. (2018). Regulation of the response of Caenorhabditis elegans to simulated microgravity by p38 mitogen-activated protein kinase signaling. Sci. Rep. 8, 857. doi:10.1038/s41598-018-19377-z

PubMed Abstract | CrossRef Full Text | Google Scholar

Licea-Herrera, J. I., Guerrero, A., Mireles-Martínez, M., Rodríguez-González, Y., Aguilera-Arreola, G., Contreras-Rodríguez, A., et al. (2024). Agricultural soil as a reservoir of Pseudomonas aeruginosa with potential risk to public health. Microorganisms 12, 2181. doi:10.3390/microorganisms12112181

PubMed Abstract | CrossRef Full Text | Google Scholar

Lin, C., Xiao, J., Xi, Y., Zhang, X., Zhong, Q., Zheng, H., et al. (2019). Rosmarinic acid improved antioxidant properties and healthspan via the IIS and MAPK pathways in Caenorhabditis elegans. Biofactors 45, 774–787. doi:10.1002/biof.1536

PubMed Abstract | CrossRef Full Text | Google Scholar

Matsumoto, T., Fujita, M., Hirano, R., Uchino, J., Tajiri, Y., Fukuyama, S., et al. (2016). Chronic Pseudomonas aeruginosa infection-induced chronic bronchitis and emphysematous changes in CCSP-deficient mice. Int. J. Chron. Obstruct Pulmon Dis. 11, 2321–2327. doi:10.2147/COPD.S113707

PubMed Abstract | CrossRef Full Text | Google Scholar

Mena, K. D., and Gerba, C. P. (2009). Risk assessment of Pseudomonas aeruginosa in water. Rev. Environ. Contam. Toxicol. 201, 71–115. doi:10.1007/978-1-4419-0032-6_3

PubMed Abstract | CrossRef Full Text | Google Scholar

Moliner, C., López, V., Barros, L., Dias, M. I., Ferreira, I., Langa, E., et al. (2020). Rosemary flowers as edible plant foods: phenolic composition and antioxidant properties in Caenorhabditis elegans. Antioxidants (Basel) 9, 811. doi:10.3390/antiox9090811

PubMed Abstract | CrossRef Full Text | Google Scholar

Nijtmans, L. G., Artal, S. M., Grivell, L. A., and Coates, P. J. (2002). The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageing and degenerative disease. Cell Mol. Life Sci. 59, 143–155. doi:10.1007/s00018-002-8411-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Park, H. H., Jung, Y., and Lee, S. V. (2017). Survival assays using Caenorhabditis elegans. Mol. Cells 40, 90–99. doi:10.14348/molcells.2017.0017

PubMed Abstract | CrossRef Full Text | Google Scholar

Petersen, M., and Simmonds, M. S. (2003). Rosmarinic acid. Phytochemistry 62, 121–125. doi:10.1016/s0031-9422(02)00513-7

PubMed Abstract | CrossRef Full Text | Google Scholar

Pujol, C., Bratic-Hench, I., Sumakovic, M., Hench, J., Mourier, A., Baumann, L., et al. (2013). Succinate dehydrogenase upregulation destabilize complex I and limits the lifespan of gas-1 mutant. PLoS One 8, e59493. doi:10.1371/journal.pone.0059493

PubMed Abstract | CrossRef Full Text | Google Scholar

Qu, M., Miao, L., Chen, H., Zhang, X., and Wang, Y. (2023). SKN-1/Nrf2-dependent regulation of mitochondrial homeostasis modulates transgenerational toxicity induced by nanoplastics with different surface charges in Caenorhabditis elegans. J. Hazard Mater 457, 131840. doi:10.1016/j.jhazmat.2023.131840

PubMed Abstract | CrossRef Full Text | Google Scholar

Schmauder, L., Sima, S., Hadj, A. B., Cesar, R., and Richter, K. (2022). Binding of the HSF-1 DNA-binding domain to multimeric C. elegans consensus HSEs is guided by cooperative interactions. Sci. Rep. 12, 8984. doi:10.1038/s41598-022-12736-x

PubMed Abstract | CrossRef Full Text | Google Scholar

Servello, F. A., and Apfeld, J. (2020). The heat shock transcription factor HSF-1 protects Caenorhabditis elegans from peroxide stress. Transl. Med. Aging 4, 88–92. doi:10.1016/j.tma.2020.07.002

CrossRef Full Text | Google Scholar

Shen, N., Zeng, W., Leng, F., Lu, J., Lu, Z., Cui, J., et al. (2021). Ginkgo seed extract promotes longevity and stress resistance of Caenorhabditis elegans. Food Funct. 12, 12395–12406. doi:10.1039/d1fo02823e

PubMed Abstract | CrossRef Full Text | Google Scholar

Spanier, B., Lasch, K., Marsch, S., Benner, J., Liao, W., Hu, H., et al. (2009). How the intestinal peptide transporter PEPT-1 contributes to an obesity phenotype in Caenorhabditits elegans. PLoS One 4, e6279. doi:10.1371/journal.pone.0006279

PubMed Abstract | CrossRef Full Text | Google Scholar

Tan, M. W., Mahajan-Miklos, S., and Ausubel, F. M. (1999). Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc. Natl. Acad. Sci. U. S. A. 96, 715–720. doi:10.1073/pnas.96.2.715

PubMed Abstract | CrossRef Full Text | Google Scholar

Thomas, P., and Sekhar, A. C. (2016). Effects due to rhizospheric soil application of an antagonistic bacterial endophyte on native bacterial community and its survival in soil: a case study with Pseudomonas aeruginosa from banana. Front. Microbiol. 7, 493. doi:10.3389/fmicb.2016.00493

PubMed Abstract | CrossRef Full Text | Google Scholar

Timmons, L. (2006). Delivery methods for RNA interference in C. elegans. Methods Mol. Biol. 351, 119–125. doi:10.1385/1-59745-151-7:119

PubMed Abstract | CrossRef Full Text | Google Scholar

Trojanowski, N. F., Raizen, D. M., and Fang-Yen, C. (2016). Pharyngeal pumping in Caenorhabditis elegans depends on tonic and phasic signaling from the nervous system. Sci. Rep. 6, 22940. doi:10.1038/srep22940

PubMed Abstract | CrossRef Full Text | Google Scholar

Van’t Wout, E. F., van Schadewijk, A., van Boxtel, R., Dalton, L. E., Clarke, H. J., Tommassen, J., et al. (2015). Virulence factors of Pseudomonas aeruginosa induce both the unfolded protein and integrated stress responses in airway epithelial cells. PLoS Pathog. 11, e1004946. doi:10.1371/journal.ppat.1004946

PubMed Abstract | CrossRef Full Text | Google Scholar

Velonakis, E., Dimitriadi, D., Papadogiannakis, E., and Vatopoulos, A. (2014). Present status of effect of microorganisms from sand beach on public health. J. Coast. Life Med. 2, 746–756. doi:10.12980/JCLM.2.2014JCLM-2014-0067

CrossRef Full Text | Google Scholar

Venz, R., Pekec, T., Katic, I., Ciosk, R., and Ewald, C. Y. (2021). End-of-life targeted degradation of DAF-2 insulin/IGF-1 receptor promotes longevity free from growth-related pathologies. Elife 10, e71335. doi:10.7554/eLife.71335

PubMed Abstract | CrossRef Full Text | Google Scholar

Villalva, M., Jaime, L., Aguado, E., Nieto, J. A., Reglero, G., and Santoyo, S. (2018). Anti-inflammatory and antioxidant activities from the basolateral fraction of caco-2 cells exposed to a rosmarinic acid enriched extract. J. Agric. Food Chem. 66, 1167–1174. doi:10.1021/acs.jafc.7b06008

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang, F., Liu, Q. D., Wang, L., Zhang, Q., and Hua, Z. T. (2012). The molecular mechanism of rosmarinic acid extending the lifespan of Caenorhabditis elegans. Appl. Mech. Mater. 140, 469–472. doi:10.4028/www.scientific.net/amm.140.469

CrossRef Full Text | Google Scholar

Wang, B., Lin, Y. C., Vasquez-Rifo, A., Jo, J., Price-Whelan, A., McDonald, S. T., et al. (2021). Pseudomonas aeruginosa PA14 produces R-bodies, extendable protein polymers with roles in host colonization and virulence. Nat. Commun. 12, 4613. doi:10.1038/s41467-021-24796-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Williams, P. D. E., Kashyap, S. S., McHugh, M. A., Brewer, M. T., Robertson, A. P., and Martin, R. J. D. (2022). TRP channels and Ca2+ signaling in cells of the Ascaris intestine. Sci. Rep. 12, 21317. doi:10.1038/s41598-022-25648-7

PubMed Abstract | CrossRef Full Text | Google Scholar

Wood, S. J., Kuzel, T. M., and Shafikhani, S. H. (2023). Pseudomonas aeruginosa: infections, animal modeling, and therapeutics. Cells 12, 199. doi:10.3390/cells12010199

PubMed Abstract | CrossRef Full Text | Google Scholar

Wu, Q., Yin, L., Li, X., Tang, M., Zhang, T., and Wang, D. (2013). Contributions of altered permeability of intestinal barrier and defecation behavior to toxicity formation from graphene oxide in nematode Caenorhabditis elegans. Nanoscale 5, 9934–9943. doi:10.1039/c3nr02084c

PubMed Abstract | CrossRef Full Text | Google Scholar

Wu, J., Shao, Y., Hua, X., and Wang, D. (2024). Activated hedgehog and insulin ligands by decreased transcriptional factor DAF-16 mediate transgenerational nanoplastic toxicity in Caenorhabditis elegans. J. Hazard Mater 480, 135909. doi:10.1016/j.jhazmat.2024.135909

PubMed Abstract | CrossRef Full Text | Google Scholar

Yang, R., Kang, Y., Duan, J., Zou, C., and Wu, Q. (2022). The p38 MAPK/PMK-1 pathway is required for resistance to nocardia farcinica infection in Caenorhabditis elegance. Pathogens 11, 1071. doi:10.3390/pathogens11101071

PubMed Abstract | CrossRef Full Text | Google Scholar

Yuan, C., Wang, Y., Zhang, L., and Wang, D. (2024). Procatechuic acid and protocatechuic aldehyde increase survival of Caenorhabditis elegans after fungal infection and inhibit fungal virulence. Front. Pharmacol. 15, 1396733. doi:10.3389/fphar.2024.1396733

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, L., Wang, Y., Cao, C., Zhu, Y., Huang, W., Yang, Y., et al. (2022). Beneficial effect of Xuebijing against Pseudomonas aeruginosa infection in Caenorhabditis elegans. Front. Pharmacol. 13, 949608. doi:10.3389/fphar.2022.949608

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, H., Gao, S., and Chen, W. (2022). Automated recognition and analysis of head thrashes behavior in C. elegans. BMC Bioinforma. 23, 87. doi:10.1186/s12859-022-04622-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, J., Zhao, Y., Sun, Z., and Sun, T. (2022a). Lacticaseibacillus rhamnosus Probio-M9 extends the lifespan of Caenorhabditis elegans. Commun. Biol. 5, 1139. doi:10.1038/s42003-022-04031-2

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, J., Cui, X., Zhang, M., Bai, B., Yang, Y., and Fan, S. (2022b). The antibacterial mechanism of perilla rosmarinic acid. Biotechnol. Appl. Biochem. 69, 1757–1764. doi:10.1002/bab.2248

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: rosmarinic acid, Pseudomonas aeruginosa, anti-infection, bacterial infection, mitochondria, Caenorhabditis elegans

Citation: Zhang Y, Shu C, Li Z, Qu M, Wang C, Nie S, Xu Q, Gu S, Fan M, Shi B, Fu L and Zhang F (2025) The protective effects and mechanisms of rosmarinic acid against Pseudomonas aeruginosa infection in Caenorhabditis elegans. Front. Pharmacol. 16:1701885. doi: 10.3389/fphar.2025.1701885

Received: 09 September 2025; Accepted: 10 November 2025;
Published: 02 December 2025.

Edited by:

Germain Sotoing Taiwe, University of Buea, Cameroon

Reviewed by:

Roberta Imperatore, University of Sannio, Italy
Verena Spiegler, University of Münster, Germany

Copyright © 2025 Zhang, Shu, Li, Qu, Wang, Nie, Xu, Gu, Fan, Shi, Fu and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Lei Fu, ZnVsZWlwYjgwQG91dGxvb2suY29t; Fenglun Zhang, ZmVuZ2x1bl9zdEBvdXRsb29rLmNvbQ==

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.